On the cost of electrodialysis for the desalination of high salinity feeds

We propose the use of electrodialysis to desalinate produced waters from shale formations in order to facilitate water reuse in subsequent hydraulic fracturing processes. We focus on establishing the energy and equipment size required for the desalination of feed waters containing total dissolved solids of up to 192,000 ppm, and we do this by experimentally replicating the performance of a 10-stage electrodialysis system. We find that energy requirements are similar to current vapour compression desalination processes for feedwaters ranging between roughly 40,000-90,000 ppm TDS, but we project water costs to potentially be lower. We also find that the cost per unit salt removed is significantly lower when removed from a high salinity stream as opposed to a low salinity stream, pointing towards the potential of ED to operate as a partial desalination process for high salinity waters. We then develop a numerical model for the system, validate it against experimental results and use this model to minimise salt removal costs by optimising the stack voltage. We find that the higher the salinity of the water from which salt is removed the smaller should be the ratio of the electrical current to its limiting value. We conclude, on the basis of energy and equipment costs, that electrodialysis processes are potentially feasible for the desalination of high salinity waters but require further investigation of robustness to fouling under field conditions.Massachusetts Institute of Technology. Office of the Dean for Graduate Education (Hugh Hampton Young Memorial Fellowship)MIT Energy Initiativ

Will our drying climate lead to the extinction of Perth's wetland fauna?

In Mediterranean climate regions like Perth, wetlands are often seasonal, and the fauna is adapted to annual wetland drying. However, with a drying climate, wetlands are drying out more frequently and/or for longer, yet so far they have retained their high biodiversity

SIAMOC position paper on gait analysis in clinical practice: General requirements, methods and appropriateness. Results of an Italian consensus conference

Gait analysis is recognized as a useful assessment tool in the field of human movement research. However, doubts remain on its real effectiveness as a clinical tool, i.e. on its capability to change the diagnostic-therapeutic practice. In particular, the conditions in which evidence of a favorable cost-benefit ratio is found and the methodology for properly conducting and interpreting the exam are not identified clearly. To provide guidelines for the use of Gait Analysis in the context of rehabilitation medicine, SIAMOC (the Italian Society of Clinical Movement Analysis) promoted a National Consensus Conference which was held in Bologna on September 14th, 2013. The resulting recommendations were the result of a three-stage process entailing i) the preparation of working documents on specific open issues, ii) the holding of the consensus meeting, and iii) the drafting of consensus statements by an external Jury. The statements were formulated based on scientific evidence or experts' opinion, when the quality/quantity of the relevant literature was deemed insufficient. The aim of this work is to disseminate the consensus statements. These are divided into 13 questions grouped in three areas of interest: 1) General requirements and management, 2) Methodological and instrumental issues, and 3) Scientific evidence and clinical appropriateness. SIAMOC hopes that this document will contribute to improve clinical practice and help promoting further research in the field

Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors

Summary CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies have displayed limited activity against established tumors. We demonstrated that CD25 expression is largely restricted to tumor-infiltrating Treg cells in mice and humans. While existing anti-CD25 antibodies were observed to deplete Treg cells in the periphery, upregulation of the inhibitory Fc gamma receptor (FcγR) IIb at the tumor site prevented intra-tumoral Treg cell depletion, which may underlie the lack of anti-tumor activity previously observed in pre-clinical models. Use of an anti-CD25 antibody with enhanced binding to activating FcγRs led to effective depletion of tumor-infiltrating Treg cells, increased effector to Treg cell ratios, and improved control of established tumors. Combination with anti-programmed cell death protein-1 antibodies promoted complete tumor rejection, demonstrating the relevance of CD25 as a therapeutic target and promising substrate for future combination approaches in immune-oncology

International Consensus Statement on Rhinology and Allergy: Rhinosinusitis

Background: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods: ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results: ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion: This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS